1. A unique clinical phenotype of a patient bearing a newly identified deletion mutation in the PSENEN gene along with the pathogenic serum desmoglein‐1 antibody. (1st April 2018) Authors: Kan, T.; Takahagi, S.; Shindo, H.; Tanaka, A.; Kawai, M.; Hide, M. Journal: Clinical and experimental dermatology Issue: Volume 43:Number 3(2018) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A unique clinical phenotype of a patient bearing a newly identified deletion mutation in the PSENEN gene along with the pathogenic serum desmoglein‐1 antibody. (4th January 2018) Authors: Kan, T.; Takahagi, S.; Shindo, H.; Tanaka, A.; Kawai, M.; Hide, M. Journal: Clinical and experimental dermatology Issue: Volume 43:Number 3(2018) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IL‐28B (IFN‐λ3) and IFN‐α synergistically inhibit HCV replication. Issue 4 (7th August 2012) Authors: Shindo, H.; Maekawa, S.; Komase, K.; Miura, M.; Kadokura, M.; Sueki, R.; Komatsu, N.; Shindo, K.; Amemiya, F.; Nakayama, Y.; Inoue, T.; Sakamoto, M.; Yamashita, A.; Moriishi, K.; Enomoto, N. Journal: Journal of viral hepatitis Issue: Volume 20:Issue 4(2013) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗